Structural Rearrangement and Retargeting of Super Enhancers

38 concepts24 papers1 proposal

To understand how a cell regulates its genes, we have to look past the linear sequence of DNA and consider its three-dimensional architecture. Within the nucleus, DNA folds into intricate loops and domains, bringing distant regulatory elements into physical contact with the genes they control. Among the most powerful of these regulatory elements are super-enhancers—large clusters of transcriptional enhancers packed with master transcription factors and chromatin activators that drive the massive expression of genes defining a cell's identity.

In a healthy cell, this 3D architecture is tightly orchestrated. However, when structural mutations break and reconnect chromosomes, they can rewire these regulatory networks. This phenomenon, known as enhancer hijacking, occurs when a powerful super-enhancer is physically relocated next to a normally silent or tightly controlled oncogene, turning a lineage-defining engine into a driver of malignancy.

Healthy State:
[ Super-Enhancer ] -------> (Lineage Gene) ... // ... [ Silent Locus ] -------> (Oncogene)

Enhancer Hijacking (Structural Rearrangement):
[ Super-Enhancer ] -------> (Oncogene)         ... // ... [ Broken Locus ] ----> (Lineage Gene)

The Mechanics of 3D Genome Disruption

Traditional cancer genetics often focuses on mutations within protein-coding sequences or simple copy-number duplications. Enhancer hijacking operates on a completely different principle: the protein-coding sequence of the oncogene remains entirely wild-type and unmutated, but its expression volume knob is turned up to a pathological maximum.

This occurs through large-scale genomic structural variants (SVs) such as inversions, translocations, and deletions. In a comprehensive analysis of over 1,200 cancer genomes, Yiqun Zhang et al. in High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations demonstrated that structural variants occurring near genes are heavily biased toward increasing gene expression rather than disrupting it. By physically moving distal enhancers into the proximity of target genes, these rearrangements increase the local density of activating elements, driving the overexpression of critical genes like TERT and PD-L1 without requiring direct coding mutations.

This global pattern is mirrored across diverse cancer types. For instance, in clear cell renal cell carcinoma (ccRCC), Yu Dong et al. in Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC showed how complex structural rearrangements disrupt normal 3D folding domains, forcing distal enhancer clusters into contact with the SEMA5B promoter to fuel tumor proliferation. Similarly, a landmark study by Paul A. Northcott et al. in The whole-genome landscape of medulloblastoma subtypes solved the genetic mystery of aggressive medulloblastoma subtypes by mapping structural DNA rearrangements that reposition highly active super-enhancers to activate the normally silent oncogene PRDM6.

Repurposing Tissue-Specific Engines

Why are these hijacked super-enhancers so devastatingly effective? The answer lies in their tissue-specific origins. Super-enhancers are evolved to sustain massive transcriptional output for genes that dictate high-volume cellular functions. When a tumor cell hijacks one of these pre-existing engines, it exploits the natural regulatory machinery of the host tissue.

A striking example of this mechanism was uncovered by Florian Haller et al. in Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. In salivary gland tumors, structural translocations relocate potent super-enhancers from genes responsible for high-volume protein and saliva secretion. By placing the master transcription factor NR4A3 under the control of these hyper-active, tissue-specific secretory enhancers, the cell forces a massive, continuous overproduction of the wild-type NR4A3 protein, triggering uncontrolled cell division.

This architectural exploitation is also a hallmark of hematological malignancies. In primary central nervous system lymphoma, Josefine Radke in The genomic and transcriptional landscape of primary central nervous system lymphoma utilized structural variant analysis to identify how genomic rearrangements reposition powerful regulatory elements near the BCL6 oncogene, driving tumor survival. As confirmed by a pan-cancer analysis of 2,658 whole genomes by Esther Rheinbay et al. in Analyses of non-coding somatic drivers in 2,658 cancer whole genomes, these non-coding structural alterations serve as primary drivers of malignancy across many human cancers by fundamentally altering expression topographies.

Enhancer Retargeting: The Subtle Shift

While large-scale chromosomal breaks physically move enhancers across long distances, a more subtle variation of this mechanism involves the redirection of an enhancer's focus within its local neighborhood. This is known as enhancer retargeting.

Instead of a massive translocation, small non-coding mutations within a gene's promoter can disrupt its ability to interact with a nearby super-enhancer. Deprived of its original target, the super-enhancer shifts its physical interactions toward a neighboring gene.

Normal Local Interaction:
[ Super-Enhancer ] =======> (Lineage Target Gene)      (Neighboring Oncogene)

Enhancer Retargeting (Promoter Mutation):
[ Super-Enhancer ] --X----> (Mutated Promoter) =======> (Neighboring Oncogene)

The authors of Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression, Rebecca J. Leeman‐Neill et al., demonstrated this phenomenon during the transformation of slow-growing follicular lymphoma into aggressive "double-hit" lymphoma. They discovered that mutations in regulatory DNA cause powerful super-enhancers to abandon their original lineage-defining targets and switch their physical looping to neighboring genes, redirecting strong regulatory signals to overexpress genes that were never the original targets of that enhancer.

Vulnerabilities of the Hijacked Hub

Understanding why super-enhancers work so efficiently also reveals how they can be defeated. Unlike typical enhancers, which operate relatively independently, super-enhancers are cooperative ecosystems. They rely on a high density of master transcription factors and co-activators (such as BRD4 and EP300) to form robust, highly concentrated regulatory hubs.

This cooperative nature makes them uniquely fragile. Because they depend on a high threshold concentration of proteins to maintain their structural integrity, super-enhancers are disproportionately sensitive to the depletion of their core components compared to typical enhancers.

This vulnerability has been systematically demonstrated using targeted perturbation assays:

This cooperative fragility opens up therapeutic windows. When a cancer relies on a hijacked or lineage-atypical super-enhancer to drive its core oncogenes, it becomes addicted to that specific regulatory hub. As shown by Birgit Knoechel et al. in Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case, mapping these atypical super-enhancer profiles can explain why specific tumors exhibit unexpected sensitivities to targeted transcriptional inhibitors. By designing therapies that disrupt the dense protein-protein interactions within these hijacked hubs, researchers can selectively shut down the expression of oncogenes while sparing normal cellular transcription.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_enhancer_hijacking_3a0c77ee,
  title = {enhancer hijacking},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/enhancer-hijacking/rdr_3a0c77eebd454aca881f1cfcf8cd24ce},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_enhancer_hijacking_3a0c77ee_v1,
  title = {enhancer hijacking},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/enhancer-hijacking/rdr_3a0c77eebd454aca881f1cfcf8cd24ce/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake